Corvus Pharmaceuticals, Inc. (CRVS) earnings date
Mar 23, 2027, after close estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 27% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 38 days, typically, give or take 19 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Thu, Nov 5, 2026 | after close | 36 | 8-K |
| Q2 FY2026 | Thu, Aug 6, 2026 | after close | 37 | 8-K |
| Q1 FY2026 | Thu, May 7, 2026 | after close | 37 | 8-K |
| Q4 FY2025 | Thu, Mar 12, 2026 | after close | 71 | 8-K |
| Q3 FY2025 | Tue, Nov 4, 2025 | after close | 35 | 8-K |
| Q2 FY2025 | Thu, Aug 7, 2025 | after close | 38 | 8-K |
| Q1 FY2025 | Thu, May 8, 2025 | after close | 38 | 8-K |
| Q4 FY2024 | Tue, Mar 25, 2025 | after close | 84 | 8-K |
What they guided beta
| Q3 FY2026 | "Angel Pharma anticipates that it will initiate a Phase 2 trial of soquelitinib in patients with asthma in Q2 2027." exhibit |
| Q3 FY2026 | "Initial data from the ALPS Phase 2 trial was published in November 2026 in an abstract and will be presented in greater detail in a poster presentation at the 68 th American Society of Hematology (ASH) Annual Meeting & Exposition in December 2026." exhibit |
| Q3 FY2026 | "The analysis was conducted by a team from Memorial Sloan Kettering Cancer Center and will be available online in the 2026 abstract supplement for the ASH Annual Meeting." exhibit |
| Q3 FY2026 | "Based on its current plans, Corvus expects its cash, cash equivalents and marketable securities to fund operations into the second quarter of 2028." exhibit |
| Q2 FY2026 | "Angel Pharma anticipates that it will initiate the Phase 2 asthma trial in early 2027." exhibit |
| Q2 FY2026 | "Based on its current plans, Corvus expects its cash, cash equivalents and marketable securities to fund operations into the second quarter of 2028." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/CRVS
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/CRVS
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/CRVS/"><img src="https://veritasdata.dev/embed/CRVS.svg" alt="CRVS earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/CRVS/)
Script
<script async src="https://veritasdata.dev/embed/CRVS.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/CRVS"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.